about
Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of CardiologyCaveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesisReal-time RT-PCR for the detection of beta-adrenoceptor messenger RNAs in small human endomyocardial biopsies.Clinical and biochemical data of endothelial function in Women Consuming Combined ContraceptivesRole of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogsNitrosylated hemoglobin levels in human venous erythrocytes correlate with vascular endothelial function measured by digital reactive hyperemiaModulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice.Statins and hypertension.Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis.Regulation of the mammalian heart function by nitric oxide.Nitric oxide and the heart: update on new paradigms.Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy.Relevance of nitric oxide for myocardial remodeling.Beta-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation.Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.Loss of Mouse P2Y6 Nucleotide Receptor Is Associated with Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy.The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues.Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart.MRI Assessment of Cardiomyopathy Induced by β1-Adrenoreceptor Autoantibodies and Protection Through β3-Adrenoreceptor Overexpression.The regulation of endothelial nitric oxide synthase by caveolin: a paradigm validated in vivo and shared by the 'endothelium-derived hyperpolarizing factor'.Beta3-adrenergic receptors in cardiac and vascular tissues emerging concepts and therapeutic perspectives.Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology.Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC.Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization.Nitric oxide synthase in post-ischaemic remodelling: new pathways and mechanisms.Low-density lipoprotein-cholesterol-induced endothelial dysfunction and oxidative stress: the role of statins.ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models.Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness.Hypoleptinemia in patients with anorexia nervosa: loss of circadian rhythm and unresponsiveness to short-term refeeding.Cardiac salvage by tweaking with beta-3-adrenergic receptors.Involvement of nitric oxide in iodine deficiency-induced microvascular remodeling in the thyroid gland: role of nitric oxide synthase 3 and ryanodine receptors.New and Emerging Therapies and Targets: Beta-3 Agonists.Enhanced expression of β3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase.Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice.Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes.Heme-nitrosylated hemoglobin and oxidative stress in women consuming combined contraceptives. Clinical application of the EPR spectroscopy.Variability of Mouse Left Ventricular Function Assessment by 11.7 Tesla MRI.Nitric oxide and cardiac function.The role of the NO pathway in the control of cardiac function.
P50
Q27024879-6025FFC4-5ED0-41CD-A656-3A8A5E1A9395Q28511504-CE906555-8349-497F-ADC6-667EA99B8294Q30773692-C7D81E86-2C73-485A-B3DB-46ED857CB6F1Q33726189-F16B8210-69CC-4F5F-A4FD-82B8132AC09EQ34195979-7AC60EBB-CAE4-4E16-9EEE-A5C1A05D778BQ35018511-4C5089E6-8E9C-4F15-87C1-756AB2DA9F1CQ35037549-6C026C34-7FC9-4E0E-B597-3939E0AF6471Q36110621-45B9CDE4-99DA-46D7-934A-F585852BF023Q36159524-E6EB0E4C-0341-4FFA-A871-FEFD062C67FEQ36177896-375A7FF9-AEC1-47C3-B205-2C22BBCE2705Q36225145-BAA0B94D-333F-49B9-B2DF-0D1DE6129877Q36629698-19FA3996-1D38-4A9F-8D18-57F8475CAE98Q36770499-2BC65459-9A2B-4BA7-A4F9-50185B23F5C8Q37018900-603BB32B-A134-4694-8BD6-ED86FFE133C6Q37090971-9887A6A6-8AD0-44D4-87B2-78242D6B9AEFQ37117338-A39A9F1A-8C26-4170-9291-9DFBF0E1091BQ37385274-64B69EB5-582D-4189-977B-DD64104493C9Q37431119-F947FAD4-66B6-45B4-B75A-AD2BBD8E607FQ37609275-D37F7648-AFA3-44E8-A92F-8E0E19D8A861Q37690123-4F6EF63D-AEF6-4557-B23D-B4B3F311C4F2Q37719311-052EFF0F-C43F-4A65-AD5F-EF1201AF81A9Q37798966-BFD4D8F3-97D5-466B-BB20-AE2F74A66518Q37822215-23D810E8-2555-4344-B78D-7345BC1CF6A9Q37895014-EEFA2B07-FC0B-4255-AEEE-F5C78F80CFDDQ37901641-601F90DB-1F63-40CF-9A5B-79E88BBA1E24Q37973992-53366A4F-7CBE-4748-B969-E267F8765386Q38127249-A7D9D51E-FFAC-422D-8650-8C01E7756044Q38191520-FE156B86-9078-436F-99FF-D3C1108A56B8Q38296415-89429D5A-943B-4541-8000-0AB00632457AQ38337871-DCB51CD1-32E5-4CFA-843F-606283273D4EQ38784206-ED916EF9-88F7-451E-A932-A6C68035BFC9Q38939587-14358864-AA24-4B9A-93BD-CC708A290A94Q39062830-C641752C-0502-4D0A-91CF-4DE42A27B5E2Q39320898-293C7508-E1EA-4A99-BDAA-F521889DBFA6Q40154338-6CECA9D1-2FF3-4262-90A1-C7EA6F589C1AQ40400999-2A9DD414-15D7-454C-895D-4067698B3BE9Q40459966-B1BFA389-8848-4254-81CF-67AE9241A78AQ40839499-44A0787F-3E4D-4DF6-9CCD-DEBC44CDD361Q41090625-FB898CA8-0DE1-48AC-85E7-F9B0073CA6C5Q41252689-639AC73A-33BB-44DC-950F-AB81E7C415C2
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jean-Luc Balligand
@ast
Jean-Luc Balligand
@en
Jean-Luc Balligand
@es
Jean-Luc Balligand
@nl
type
label
Jean-Luc Balligand
@ast
Jean-Luc Balligand
@en
Jean-Luc Balligand
@es
Jean-Luc Balligand
@nl
prefLabel
Jean-Luc Balligand
@ast
Jean-Luc Balligand
@en
Jean-Luc Balligand
@es
Jean-Luc Balligand
@nl
P106
P1153
7003921084
P31
P496
0000-0002-0522-4156